Study on Efficacy and Safety of Reparixin in the Treatment of Hospitalized Patients With Severe COVID-19 Pneumonia.
Clinical trial NCT04878055 · COMPLETED
Trial details
- NCT number
- NCT04878055
- Sponsor
- Dompé Farmaceutici S.p.A
- Status
- COMPLETED
- Phase
- Phase 3
- Study type
- INTERVENTIONAL
- Start date
- 2021-02-14
- Primary completion
- 2021-09-30
- Enrollment
- 287
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.